Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models
about
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerInsulin-like growth factor system in cancer: novel targeted therapiesSIGLEC12, a human-specific segregating (pseudo)gene, encodes a signaling molecule expressed in prostate carcinomasInsulin-like growth factor-binding protein 5 (Igfbp5) compromises survival, growth, muscle development, and fertility in miceThe TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to BoneCluster-based network model for time-course gene expression data.Mechanisms by which IGF-I may promote cancerTherapeutic efficacy of adenoviral-mediated p53 gene transfer is synergistically enhanced by combined use of antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model.20(S)-protopanaxadiol inhibition of progression and growth of castration-resistant prostate cancer.Methylselenocysteine preventing castration-resistant progression of prostate cancermPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model.Pitavastatin Regulates Ang II Induced Proliferation and Migration via IGFBP-5 in VSMCProteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancerInsulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.Flaxseed and its components differentially affect estrogen targets in pre-neoplastic hen ovariesMultifunctional roles of insulin-like growth factor binding protein 5 in breast cancer.Differences in phenotype and gene expression of prostate stromal cells from patients of varying ages and their influence on tumour formation by prostate epithelial cellsSecreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling.Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells.Tumor-associated retinal astrocytes promote retinoblastoma cell proliferation through production of IGFBP-5Hsp27 promotes insulin-like growth factor-I survival signaling in prostate cancer via p90Rsk-dependent phosphorylation and inactivation of BAD.Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer.The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressivenessRegulation of Androgen Receptor by E3 Ubiquitin Ligases: for More or Less.
P2860
Q26738703-A57D43C0-C65E-4A2A-BF86-F191C602F401Q28081603-47D12CAA-FD3B-49D3-8B1D-042097FAB8E7Q28237131-C51DCC83-FF0F-42DA-B012-860323CC0B92Q28512324-F0F08ADD-C1CC-4EF2-93FF-680AF20E6E7AQ30299930-6D8B9270-727E-435A-9FAA-E76B7244E037Q31061321-FEC27B70-F1C4-4078-ACA4-10FF846540ADQ34180961-3ACBAD89-C219-45ED-B2F4-3F0801155851Q34768315-FB130EE2-4126-43ED-BF9E-CACD447DDB42Q35399276-23509DB2-5B48-422F-9606-2253835B4DCBQ35582612-118E3B29-44B4-423E-8C8D-F7FE9B5DF03EQ35921941-37D89CD3-9D34-48B3-ABB1-179E607728DDQ36072803-CEC0ED87-4291-4D8E-85C0-5616DC9E78DBQ36260730-5EED6B06-CDAF-4F45-89AE-4A9C1A301F07Q36298306-3C76F47D-C380-40BD-8F70-0ED290726038Q36417183-9E41B846-A955-49F9-8E74-3E6D712EAFEDQ36767559-70C04F20-C1F4-4A07-B7F7-770F211A1886Q36955081-F738AAF7-B0A5-4CDA-8803-A327EE88ACB3Q37085297-C476E1E8-2E1C-4267-80F8-F82AC6437891Q37210786-CB644D2F-B227-4E0A-A6CB-14874DF8F498Q37418923-870FF3AB-1351-4A0B-8685-C537987C8229Q37424118-85CA265C-E6AC-4F12-92AF-C9891EAF0325Q39699324-E6AC9B92-0F0F-4C5E-8BE7-078C327FAF44Q40846906-C9143C33-FA73-4C35-8214-A7007DB2208AQ41510377-EFED878C-28D7-46D8-944F-DA7F763D2F53Q41558039-2A9A417E-1198-46D7-B0FC-322E2F089C8FQ42821302-7975EBDF-2AD8-4D89-81A3-965B0E25F9C0
P2860
Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Castration-induced up-regulati ...... ence in prostate cancer models
@ast
Castration-induced up-regulati ...... ence in prostate cancer models
@en
Castration-induced up-regulati ...... ence in prostate cancer models
@nl
type
label
Castration-induced up-regulati ...... ence in prostate cancer models
@ast
Castration-induced up-regulati ...... ence in prostate cancer models
@en
Castration-induced up-regulati ...... ence in prostate cancer models
@nl
prefLabel
Castration-induced up-regulati ...... ence in prostate cancer models
@ast
Castration-induced up-regulati ...... ence in prostate cancer models
@en
Castration-induced up-regulati ...... ence in prostate cancer models
@nl
P2093
P3181
P356
P1433
P1476
Castration-induced up-regulati ...... ence in prostate cancer models
@en
P2093
P2888
P304
P3181
P356
10.1038/SJ.PCAN.4500440
P407
P577
2000-06-01T00:00:00Z
P5875
P6179
1047830669